Report Categories Report Categories

Report Categories

industry Category

All

Total: 4 records, 1 pages

Global GM1 Gangliosidosis Treatment Supply, Demand and Key Producers, 2024-2030

date 14 Feb 2024

date Pharma & Healthcare

new_biaoQian GM1 Gangliosidosis Treatment

The global GM1 Gangliosidosis Treatment market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global GM1 Gangliosidosis Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 12 Jan 2024

date Pharma & Healthcare

new_biaoQian GM1 Gangliosidosis Treatment

According to our (Global Info Research) latest study, the global GM1 Gangliosidosis Treatment market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

Add To Cart

Add To Cart

Global GM1 Gangliosidosis Treatment Supply, Demand and Key Producers, 2023-2029

date 20 Feb 2023

date Pharma & Healthcare

new_biaoQian GM1 Gangliosidosis Treatment

The global GM1 Gangliosidosis Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

Global GM1 Gangliosidosis Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 08 Jan 2023

date Pharma & Healthcare

new_biaoQian GM1 Gangliosidosis Treatment

GM1 Gangliosidosis is an inherited central nervous system disorder that destroys nerve cells in the spinal cord and brain.

USD3480.00

Add To Cart

Add To Cart

industry 14 Feb 2024

industry Pharma & Healthcare

new_biaoQian GM1 Gangliosidosis Treatment

The global GM1 Gangliosidosis Treatment market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 12 Jan 2024

industry Pharma & Healthcare

new_biaoQian GM1 Gangliosidosis Treatment

According to our (Global Info Research) latest study, the global GM1 Gangliosidosis Treatment market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

addToCart

Add To Cart

industry 20 Feb 2023

industry Pharma & Healthcare

new_biaoQian GM1 Gangliosidosis Treatment

The global GM1 Gangliosidosis Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart

industry 08 Jan 2023

industry Pharma & Healthcare

new_biaoQian GM1 Gangliosidosis Treatment

GM1 Gangliosidosis is an inherited central nervous system disorder that destroys nerve cells in the spinal cord and brain.

USD3480.00

addToCart

Add To Cart